The Synthetic Biology Innovation Network

Search Funds: A New Model for Innovation in the Synthetic Biology Industry

Search funds could be a powerful accelerant to bring the tools of synthetic biology to a wider audience, bringing about the promise of synbio to previously untouched fields.

Two Unicorns Shaping the Future of the Synthetic Biology Industry

Often compared, Ginkgo Bioworks and Zymergen are differentiated by technology stack and business approach

Your Car Is More Plastic Than You Know. This Company May Soon Be Brewing Its Parts With Biology.

One-third of a car's parts are plastic. If a new way of making plastic with biology plays out, not only could we have lighter and more fuel-efficient automobiles, we could also enter an era of guilt-free plastic.

Will programming a cell ever be as easy as programming an app?

The promised democratization of biology plays out as industry frontrunners consolidate early leads and bio-preneurs consider the sheer breadth of opportunity

Featured

COVID-19 Resources

SynBioBeta is proud to partner with Leaps by Bayer to make a visual timeline for COVID-19 treatment and prevention. The scientific community is working around the clock, not only to protect us from COVID-19, but to...

Editors' picks

Search Funds: A New Model for Innovation in the Synthetic Biology Industry

To the scientists, researchers, founders and investors in the field, synthetic biology may excite because of its science-fiction quality technologies. It may excite because of its potential to solve some of the world’s...

Two Unicorns Shaping the Future of the Synthetic Biology Industry

Your Car Is More Plastic Than You Know. This Company May Soon Be Brewing Its Parts With Biology.

A new partnership aims to brew the raw materials needed for greener bioplastics Henry Ford made a splash at the 1941 city festival in Dearborn, Michigan. There, he and his team of chemists debuted a car unlike any the...

Will programming a cell ever be as easy as programming an app?

A Next-Generation Infant Formula—The Closest To Mother’s Milk Yet—Made With Biology

Have your cake and eat it too, so long as they’re GMO: 5 Reasons GMO should be on your shopping list

Impossible Burger is a household name best recognized for its successful introduction of a plant-based burger that “bleeds” and has no animal hormones or antibiotics. But, there is another notable “first” for Impossible...

Despite Coronavirus, 85% Of Americans Are Thinking About Sustainability As Much As Or More Than Ever

A New Test May Show Whether Your Immune System Can Neutralize The Coronavirus

Many of us are asking: Have I already been exposed to the coronavirus, and am I immune to further infection? A fast, easy, and sensitive new antibody test detects the specific biomarkers of long-term immune protection...

Built With Biology Summit – The Future is Now: Integrating Biodesign Into the Beauty Industry Today

Built With Biology Summit – Is Precision Fermentation the Transformational Technology for Cosmetics and Fashion?

View all posts

Press releases

Kalion Inc. Receives NSF Phase II SBIR Grant to Develop Bio-based Glucaric Acid

MILTON, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) — Kalion Inc. (pronounced KAL-LEE-ON) has been awarded a National Science Foundation (NSF) Phase II Small Business Research (SBIR) grant for $746,822 to conduct...

Novome Biotechnologies Expands Therapeutic Focus and Platform Capabilities with Acquisition of Preclinical Projects and Intellectual Property from Caribou Biosciences and License to CRISPR-Cas9 Foundational Patent Portfolio

− Transfer of Caribou’s novel microbial IP will enable new therapeutic opportunities for Novome − − License to CRISPR-Cas9 intellectual property controlled by Caribou will accelerate the development of preclinical...

Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2

Dartmouth-Hitchcock Health Researchers Evaluating Sherlock™ CRISPR SARS-CoV-2 Kit to Test Real-world Samples from Member Hospitals; Results Expected in Coming Weeks August 12, 2020 08:30 AM Eastern Daylight Time...

Precigen ActoBio Announces Positive Topline Results from Phase 1b Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes

– Primary endpoint met assessing safety and tolerability in the Phase 1b monotherapy portion of the study – – Preliminary results demonstrate an encouraging trend in C-peptide levels, a biomarker for...

New Cyrus Biotechnology Antibody Structure Prediction Software “NextGen” Outperforms Schrödinger and Other Software in Third-Party Test

Collaboration with BIOCAD compares top algorithms to Cyrus NextGen August 10, 2020 05:30 AM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–Cyrus Biotechnology, Inc., today announced it has developed new...

Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering

Long Beach, CA, Aug. 04, 2020 (GLOBE NEWSWIRE) — Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald”), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical...

Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline

CAMBRIDGE, Mass. and SOMERSET, N.J., July 29, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, and Catalent, the leading global provider of advanced delivery...

Elo Life Systems Announces Strategic Partnership with Dole Food Company with the Goal of Saving the Cavendish Banana

DURHAM, N.C., Aug. 04, 2020 (GLOBE NEWSWIRE) — Elo Life Systems, a food and agriculture company with a mission to improve human health and wellness, today announced a strategic partnership with the Dole Food...

AbCellera Provides COVID-19 Program Update with the Start of Phase 3 Clinical Trials and the Expansion of its COVID-19 Antibody Database

As LY-CoV555 advances into Phase 3 COVID-19 prevention studies, AbCellera’s COVID-19 database reaches over 2,000 new antibodies against the virus, discovered from recovered patient samples AUGUST 3, 2020 VANCOUVER...

CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy

– Plans to Initiate Phase 1 Clinical Trial This Year – Expands Corporate Advisors with Board of Directors and Scientific Advisory Board Appointments PHILADELPHIA, July 27, 2020 /PRNewswire/ — CARISMA...

Mantra Bio Announces $25 Million Series A Financing to Develop Next Generation Targeted Therapeutics Based on Platform for Engineering Targeted Exosome Vehicles

8VC’s Francisco Gimenez, Ph.D., Joins Company Board of Directors SAN FRANCISCO, July 29, 2020 /PRNewswire/ — Mantra Bio today announced it has raised $25 million in a Series A financing to advance...

Versant Ventures Launches Bright Peak Therapeutics

–Next-wave engineered protein company with pipeline of cytokine therapeutics developed in Versant’s Ridgeline Discovery Engine– –First IL-2 development candidate shows superior properties to all known...

Featured

COVID-19 Resources

Editors' picks

Search Funds: A New Model for Innovation in the Synthetic Biology Industry

Two Unicorns Shaping the Future of the Synthetic Biology Industry

Your Car Is More Plastic Than You Know. This Company May Soon Be Brewing Its Parts With Biology.

Will programming a cell ever be as easy as programming an app?

A Next-Generation Infant Formula—The Closest To Mother’s Milk Yet—Made With Biology

Have your cake and eat it too, so long as they’re GMO: 5 Reasons GMO should be on your shopping list

Despite Coronavirus, 85% Of Americans Are Thinking About Sustainability As Much As Or More Than Ever

A New Test May Show Whether Your Immune System Can Neutralize The Coronavirus

Built With Biology Summit – The Future is Now: Integrating Biodesign Into the Beauty Industry Today

Built With Biology Summit – Is Precision Fermentation the Transformational Technology for Cosmetics and Fashion?

Press releases

Kalion Inc. Receives NSF Phase II SBIR Grant to Develop Bio-based Glucaric Acid

Novome Biotechnologies Expands Therapeutic Focus and Platform Capabilities with Acquisition of Preclinical Projects and Intellectual Property from Caribou Biosciences and License to CRISPR-Cas9 Foundational Patent Portfolio

Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2

Precigen ActoBio Announces Positive Topline Results from Phase 1b Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes

New Cyrus Biotechnology Antibody Structure Prediction Software “NextGen” Outperforms Schrödinger and Other Software in Third-Party Test

Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering

Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline

Elo Life Systems Announces Strategic Partnership with Dole Food Company with the Goal of Saving the Cavendish Banana

AbCellera Provides COVID-19 Program Update with the Start of Phase 3 Clinical Trials and the Expansion of its COVID-19 Antibody Database

CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy

Mantra Bio Announces $25 Million Series A Financing to Develop Next Generation Targeted Therapeutics Based on Platform for Engineering Targeted Exosome Vehicles

Versant Ventures Launches Bright Peak Therapeutics

News by topic

Agriculture

Health and medicine

Funding & investments

Biomanufacturing, chemicals & materials

Emerging technologies

Food and nutrition

Consumer goods

Energy & environment

Policy & public